Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …

L Wittkop, HF Günthard, F De Wolf, D Dunn… - The Lancet infectious …, 2011 - thelancet.com
Background The effect of transmitted drug resistance (TDR) on first-line combination
antiretroviral therapy (cART) for HIV-1 needs further study to inform choice of optimum drug …

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …

L Wittkop, HF Günthard, F de Wolf, D Dunn… - The Lancet Infectious …, 2011 - Elsevier
BACKGROUND: The effect of transmitted drug resistance (TDR) on first-line combination
antiretroviral therapy (cART) for HIV-1 needs further study to inform choice of optimum drug …

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …

L Wittkop, F Huldrych, F De Wolf, D Dunn… - THE LANCET …, 2011 - usiena-air.unisi.it
Background: The effect of transmitted drug resistance (TDR) on first-line combination
antiretroviral therapy (cART) for HIV-1 needs further study to inform choice of optimum drug …

Eff ect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …

L Wittkop, FG Huldrych, F De Wolf, D Dunn… - THE LANCET …, 2011 - publicatt.unicatt.it
Background The eff ect of transmitted drug resistance (TDR) on fi rst-line combination
antiretroviral therapy (cART) for HIV-1 needs further study to inform choice of optimum drug …

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …

L Wittkop, HF Günthard, F de Wolf… - Lancet Infectious …, 2011 - research.regionh.dk
The effect of transmitted drug resistance (TDR) on first-line combination antiretroviral therapy
(cART) for HIV-1 needs further study to inform choice of optimum drug regimens. We …

[引用][C] Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint …

L Wittkop, HF Günthard, F de Wolf, D Dunn… - The Lancet infectious …, 2011 - dial.uclouvain.be

[引用][C] Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint …

L WITTKOP, HF GUNTHARD… - Lancet. Infectious …, 2011 - pascal-francis.inist.fr
Effect of transmitted drug resistance on virological and immunological response to initial
combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European …

[PDF][PDF] Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint …

L Wittkop, HF Günthard, F de Wolf, D Dunn… - Lancet Infect Dis, 2011 - chip.dk
Background The effect of transmitted drug resistance (TDR) on first-line combination
antiretroviral therapy (cART) for HIV-1 needs further study to inform choice of optimum drug …

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …

L Wittkop, HF Günthard, F de Wolf, D Dunn… - Lancet Infect …, 2011 - thelancet.com
Background The effect of transmitted drug resistance (TDR) on first-line combination
antiretroviral therapy (cART) for HIV-1 needs further study to inform choice of optimum drug …

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …

L Wittkop, HF Günthard, F de Wolf, D Dunn… - The Lancet. Infectious …, 2011 - europepmc.org
Background The effect of transmitted drug resistance (TDR) on first-line combination
antiretroviral therapy (cART) for HIV-1 needs further study to inform choice of optimum drug …